in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Merck KGaA and Lonza Make Bioscience Acquisitions in Bangalore, India
7:32 AM MDT | October 16, 2009 | Alex Scott
Lonza says it has acquired the preclinical cell and molecular biology assets of Simbiosys Biowares India (Bangalore, India), a biology outsourcing company. In a separate move, Merck KGaA says it has acquired Bangalore Genei (Bangalore), a bioscience group, from its parent company Sanmar Specialty Chemicals (Chennai, India). Financial terms of both deals were not disclosed. Simbiosys provides competencies in cell and molecular biology and clinical services, Lonza says. The business’s cell and molecular biology group specializes in primary cell...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee